Mrv1909 12041923282D 11 11 0 0 0 0 999 V2000 -0.3572 -1.2374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0716 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 -1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7861 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.4125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 5 6 1 0 0 0 0 1 6 2 0 0 0 0 6 7 1 0 0 0 0 5 8 1 0 0 0 0 8 9 1 0 0 0 0 8 10 2 0 0 0 0 3 11 1 0 0 0 0 M END > DB12466 > drugbank > NC(=O)C1=NC(F)=CN=C1O > InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11) > ZCGNOVWYSGBHAU-UHFFFAOYSA-N > C5H4FN3O2 > 157.104 > 157.028754544 > 4 > 15 > 12.123878906367722 > 1 > 2 > 0 > 0 > 6-fluoro-3-hydroxypyrazine-2-carboxamide > 0.49 > 0.25191639600000004 > -1.26 > 0 > 1 > 0 > 13.579307723139335 > 9.39401731404919 > -3.6791532864267253 > 89.1 > 33.9761 > 1 > 1 > 8.70e+00 g/l > [(2R,3S,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxyphosphonic acid > 0 > DB12466 > DB06046; DB15625 > approved; investigational > Favipiravir > Fapilavir; Favilavir; Favipiravir > Avigan $$$$